Publications Hübschmann Group

About us
- - Back
  - Prof. Dr. Andreas Trumpp
    
    Dr. Marieke Essers
    
    Dr. Michael Milsom
    
    Dr. Martin Sprick
    
    Dr. Marc Thier
    
    Dr. Simon Haas
    
    Dr. Dr. Daniel
    Hübschmann
    
    Dr. Rene Jackstadt
    
    Dr. Hamed Alborzinia
Research
- - Back
  - Normal & Malignant
    Stem Cells
    
    Head:
    Prof. Dr. Andreas Trumpp
    
    Experimental
    Hematology
    
    Head:
    Dr. Mick Milsom
    
    Inflammatory Stress
    in Stem Cells
    
    Head:
    Dr. Marieke Essers
    
    Pattern Recognition &
    Digital Medicine
    
    Head:
    Dr. Dr. Daniel Hübschmann
    
    Stem Cells at the
    Interface of
    Hematopoiesis,
    Immunity & Cancer
    
    Head:
    Dr. Simon Haas
    
    Neural
    Reprogramming
    and Clinical
    Translation
    
    Head:
    Dr. Marc Thier
    
    Stem Cells and
    Metastases
    
    Head:
    Dr. Martin Sprick
    Prof. Dr. Andreas Trumpp
    
    Cancer Progression
    and Metastasis
    
    Head:
    Dr. Rene Jackstadt
  - Normal and Malignant Stem Cells
  - Experimental Hematology
  - Stem Cells and Metastases
  - Neural Reprogramming and Clinical Translation
  - Pattern Recognition
  - Stem Cells at the Interface of hematopoiesis, Immunity and Cancer
  - Stress Induced Activation of Hematopoietic Stem Cells
  - Cancer Progression and Metastasis
Outreach and Teaching
Publications
News
Search ...

Enter Part of Title

Display #

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma (Nature Communications, 2019)
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma (Nature Communications, 2019)
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (Acta Neuropathologica, 2019)

HI-STEM Movie

Larger Version

News

June 03, 2025

HI-STEM Group Leaders part of the new DFG funded collaborative research center for blood cancer

The German Research Foundation (DFG) will support the new Collaborative Research Center (SFB) 1709 “Cellular Plasticity in Malignant Myeloid Diseases – From Mechanism to Therapy” over the next four years. In around 20 working groups, scientists will…